Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors
Abstract Loss of the RAS GTPase-activating protein (RAS-GAP) NF1 drives aberrant activation of RAS/MEK/ERK signaling and other effector pathways in the majority of malignant peripheral nerve sheath tumors (MPNST). These dysregulated pathways represent potential targets for therapeutic intervention....
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
2020
|
| Online Erişim: | https://doi.org/10.1158/0008-5472.can-20-1365 https://cancerres.aacrjournals.org/content/canres/80/23/5367.full.pdf |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|